[HTML][HTML] 超声引导下细针穿刺洗脱液测定BRAFV600E突变丰度预测甲状腺乳头状癌颈部淋巴结转移

栾梦琪, 夏蜀珺, 林琳, 张桂萍… - 中华医学超声杂志 …, 2021 - chaosheng.cma-cmc.com.cn
BRAF V600E mutation abundance determined based on ultrasound-guided fine needle …
lymph node metastasis in papillary thyroid cancer[J]. Chinese Journal of Medical Ultrasound (…

碘难治性分化型甲状腺癌靶向药物治疗进展

李盼丽, 宋少莉 - 国际放射医学核医学杂志, 2016 - ijrmnm.com
… of molecular targeted therapy about refractory thyroid cancer. … Molecular pathogenesis and
mechanisms of thyroid can鄄 … A1799-1816ins BRAF mutations in papillary thyroid cancer[J]. …

[HTML][HTML] 甲状腺癌发生的分子机制及其临床应用

张洁 - Advances in Clinical Medicine, 2023 - hanspub.org
… reviews the molecular mechanisms and clinical relevance related to different pathological
pathogenesis of thyroid cancer. … 在间变性甲状腺癌患者中,94%的BRAF突变为BRAF V600E突变.…

[PDF][PDF] 甲状腺癌诊断及预后相关分子标志物的研究进展

梅志丹, 陈晨, 胡章威, 郑安元, 陶泽璋 - 现代生物医学进展, 2017 - biomed.cnjournals.com
… made in developing molecular markers for clinical use. With … molecular alterations of BRAF
in the pathogenesis of thyroid … aggressive BRAF wild-type papillary thyroid cancer identified …

对乳头状甲状腺癌临床分子靶标的筛选

杨迟晖, 张晶, 孟磊俊, 宫丽平, 常庆, 张泓… - 诊断学理论与 …, 2019 - qk.sjtu.edu.cn
BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical
The prevalence and prognostic value of BRAF mutation in thyroid cancer[J]. Ann surg,2007,…

甲状腺结节细针穿刺分子标志物的研究进展

张杰, 刘媛超, 谭建 - 中国肿瘤临床, 2018 - cjco.cn
BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical
fine needle aspiration BRAF(V600E) mutation analysis in papillary thyroid cancer: a systematic …

PTEN 和Notch1 在结直肠癌组织中的表达及临床意义

孙刚, 江永强, 祁真玉 - 蚌埠医学院学报, 2014 - xuebao.bbmu.edu.cn
… PTC 的BRAF 基因突变与甲状腺过氧化酶和 Na + / I鄄 同向转运体基因的低表达有关,对BRAF
突 变基因型的PTC 患者术后行 131 I 放射性辅助治疗可 能无效. 因此,检测BRAF 基因突变对于…

[PDF][PDF] 甲状腺癌基因诊断与基因治疗的研究进展

孙凤, 韦伟 - JOURNAL OF RARE AND UNCOMMON DISEASES, 2015 - diagnoschina.com
… with prognostic factors and poor clinical outcome in papillary thyroid cancer: a meta-analysis…
BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical

乳腺癌合并甲状腺癌致病因素的研究进展

姜欢, 赵睿, 戴绍春 - 肿瘤防治研究, 2021 - zlfzyj.com
… This article reviews the pathogenic factors between these … 织,甲状腺乳头状癌(papillary thyroid
carcinoma, PTC)中的NIS表达… by RET/PTC gene rearrangement or BRAF mutation in PTC …

[PDF][PDF] 甲状腺乳头状癌中BRAFT1799A 基因点突变及其与临床病理特征的关系分析

刘丽云, 胡月明, 李岩冰, 龚健 - 中国普通外科杂志, 2018 - zpwz.net
BRAF T1799A gene mutation in papillary thyroid carcinoma: a living … of mutated BRAF V600E
supports the clonal origin of BRAF-… mutation with clinical pathological features in papillary